In fact, several lines of evidence suggested that inhibition of IL‐6/STAT3 pathway exerts protective effects against LPS‐induced ALI, implying that IL‐6R‐targeted therapy is an effective strategy to alleviate ALI in SIRS.52, 53. The gene discussed is IL6R; the disease is systemic inflammatory response syndrome.